Birdwatch Note
2023-11-01 10:28:10 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
イベルメクチンは駆虫薬であり、明確な効果がでた場合、糞線虫など寄生生物駆除による効果が考えられます https://medical.nikkeibp.co.jp/inc/all/drugdic/article/56133a775595b3d40b7965e1.htm またコロナウイルスに対する効果について国内の販売元である興和による臨床試験でも有効性は認められず販売を断念しています https://www.chemicaldaily.co.jp/%e8%88%88%e5%92%8c%e3%80%81%e3%80%8c%e3%82%a4%e3%83%99%e3%83%ab%e3%83%a1%e3%82%af%e3%83%81%e3%83%b3%e3%80%8d%e3%81%ae%e3%82%b3%e3%83%ad%e3%83%8a%e9%81%a9%e5%bf%9c%e3%80%81%e6%9c%89%e5%8a%b9%e6%80%a7/ さらに米国FDAもCOVID19に対する効果は認めていません https://ktla.com/news/nationworld/ivermectin-still-not-effective-or-approved-for-covid-19-treatment-fda-says/ 米国では馬用のイベルメクチンを使用した事例が発生、大量接種による健康被害が出ており、注意喚起を行っています https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 薬には副作用があります。万が一本動画を信じこみ服用後、以下のリンク先に記載された症状が出た場合は速やかに医療機関へ相談してください https://www.pmda.go.jp/files/000243238.pdf
Written by 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1719572428840632431
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1719662609027449241
- noteId - 1719662609027449241
- participantId -
- noteAuthorParticipantId - 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858 Participant Details
- createdAtMillis - 1698834490435
- tweetId - 1719572428840632431
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- イベルメクチンは駆虫薬であり、明確な効果がでた場合、糞線虫など寄生生物駆除による効果が考えられます https://medical.nikkeibp.co.jp/inc/all/drugdic/article/56133a775595b3d40b7965e1.htm またコロナウイルスに対する効果について国内の販売元である興和による臨床試験でも有効性は認められず販売を断念しています https://www.chemicaldaily.co.jp/%e8%88%88%e5%92%8c%e3%80%81%e3%80%8c%e3%82%a4%e3%83%99%e3%83%ab%e3%83%a1%e3%82%af%e3%83%81%e3%83%b3%e3%80%8d%e3%81%ae%e3%82%b3%e3%83%ad%e3%83%8a%e9%81%a9%e5%bf%9c%e3%80%81%e6%9c%89%e5%8a%b9%e6%80%a7/ さらに米国FDAもCOVID19に対する効果は認めていません https://ktla.com/news/nationworld/ivermectin-still-not-effective-or-approved-for-covid-19-treatment-fda-says/ 米国では馬用のイベルメクチンを使用した事例が発生、大量接種による健康被害が出ており、注意喚起を行っています https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 薬には副作用があります。万が一本動画を信じこみ服用後、以下のリンク先に記載された症状が出た場合は速やかに医療機関へ相談してください https://www.pmda.go.jp/files/000243238.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-01 10:28:10 UTC (1698834490435) |
2023-11-01 15:07:38 UTC (1698851258796) |
CURRENTLY_RATED_HELPFUL | 2023-11-02 07:47:06 UTC (1698911226426) |
CURRENTLY_RATED_HELPFUL | 2023-11-01 15:07:38 UTC (1698851258796) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-11-01 08:12:57 -0500 | Rating Details | |
2023-11-01 08:08:30 -0500 | Rating Details | |
2023-11-01 07:41:40 -0500 | Rating Details | |
2023-11-01 07:32:43 -0500 | Rating Details | |
2023-11-01 07:27:25 -0500 | Rating Details | |
2023-11-01 07:22:11 -0500 | Rating Details | |
2023-11-01 07:19:34 -0500 | Rating Details | |
2023-11-01 07:10:30 -0500 | Rating Details | |
2023-11-01 07:05:13 -0500 | Rating Details | |
2023-11-01 06:59:36 -0500 | Rating Details | |
2023-11-01 06:12:06 -0500 | Rating Details | |
2023-11-01 06:03:21 -0500 | Rating Details | |
2023-11-01 06:02:03 -0500 | Rating Details | |
2023-11-01 05:54:52 -0500 | Rating Details | |
2023-11-01 05:52:47 -0500 | Rating Details | |
2023-11-01 05:30:56 -0500 | Rating Details | |
2023-11-01 05:28:59 -0500 | Rating Details | |
2023-11-03 19:27:02 -0500 | Rating Details | |
2023-11-01 11:10:12 -0500 | Rating Details | |
2023-11-01 09:58:16 -0500 | Rating Details | |
2023-11-01 09:46:33 -0500 | Rating Details | |
2023-11-01 09:41:49 -0500 | Rating Details | |
2023-11-01 08:37:59 -0500 | Rating Details | |
2023-11-01 08:36:52 -0500 | Rating Details | |
2023-11-01 08:34:29 -0500 | Rating Details | |
2023-11-01 08:25:45 -0500 | Rating Details | |
2023-11-01 08:10:52 -0500 | Rating Details | |
2023-11-01 07:51:30 -0500 | Rating Details | |
2023-11-01 07:35:14 -0500 | Rating Details | |
2023-11-01 07:08:08 -0500 | Rating Details | |
2023-11-01 07:05:39 -0500 | Rating Details | |
2023-11-01 06:57:26 -0500 | Rating Details | |
2023-11-01 06:52:23 -0500 | Rating Details | |
2023-11-01 06:50:37 -0500 | Rating Details | |
2023-11-01 06:25:24 -0500 | Rating Details | |
2023-11-01 06:05:06 -0500 | Rating Details | |
2023-11-01 06:03:19 -0500 | Rating Details | |
2023-11-01 05:58:43 -0500 | Rating Details | |
2023-11-01 05:55:40 -0500 | Rating Details | |
2023-11-01 05:41:10 -0500 | Rating Details | |
2023-11-01 05:38:14 -0500 | Rating Details | |
2023-11-01 05:33:45 -0500 | Rating Details | |
2023-11-03 22:27:20 -0500 | Rating Details | |
2023-11-06 16:11:08 -0600 | Rating Details | |
2023-11-06 05:15:33 -0600 | Rating Details | |
2023-11-01 23:19:28 -0500 | Rating Details | |
2023-11-18 13:13:58 -0600 | Rating Details | |
2023-11-19 00:25:18 -0600 | Rating Details | |
2024-07-10 13:57:14 -0500 | Rating Details |